Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-52,194
Closed -$6.75M 548
2024
Q1
$6.75M Buy
+52,194
New +$6.31M 0.67% 11
2023
Q4
Sell
-26,164
Closed -$2.38M 770
2023
Q3
$2.38M Sell
26,164
-4,791
-15% -$494K 0.29% 122
2023
Q2
$3.49M Buy
+30,955
New +$3.27M 0.44% 57
2023
Q1
Sell
-3,787
Closed -$419K 798
2022
Q4
$419K Buy
+3,787
New +$397K 0.05% 471
2022
Q3
Sell
-2,840
Closed -$222K 773
2022
Q2
$222K Sell
2,840
-27
-0.9% -$2.23K 0.02% 560
2022
Q1
$244K Buy
+2,867
New +$275K 0.03% 584

Other funds holding XYL

Duality Advisers's XYL Position: Q2 2024 in Review

Duality Advisers sold out of Xylem (XYL) in Q2 2024, closing a stake of 52,194 shares — an estimated $6.75M sold.

Duality Advisers first reported a position in XYL in Q1 2022 and held it in 6 quarters. The position peaked at $6.75M in Q1 2024. 1,034 funds tracked by Wall St. Rank hold XYL as of Q2 2024.

  • Duality Advisers reported no remaining Xylem position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 52,194 Xylem shares in Q2 2024, an estimated $6.75M.
  • Duality Advisers first reported a position in Xylem in Q1 2022 and held it in 6 quarters.
  • Duality Advisers's Xylem position peaked at $6.75M in Q1 2024.
  • 1,034 funds tracked by Wall St. Rank held Xylem as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.